|4Jan 6, 4:15 PM ET

Gruber James R. 4

4 · Eton Pharmaceuticals, Inc. · Filed Jan 6, 2025

Insider Transaction Report

Form 4
Period: 2025-01-03
Gruber James R.
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units

    2025-01-03+25,87625,876 total
    Common Stock (25,876 underlying)
  • Award

    Employee Stock Option (Right to Buy)

    2025-01-03+38,62138,621 total
    Exercise: $13.00Exp: 2035-01-02Common Stock (38,621 underlying)
Footnotes (3)
  • [F1]The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 3, 2029.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
  • [F3]The restricted stock units vest in four equal annual installments beginning January 3, 2026, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4 - JG 01.06.25